StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
DEEPAKCHEM.BO$86.76+4.28%
Fair $86.76+0.0%

DEEPAKCHEM.BO

Deepak Chemtex Ltd

Basic Materials / Specialty ChemicalsBSE

$86.76

+3.93 (+4.28%)

Fairly Valued+0.0%Fair Value $86.76Fund rank 25/100 · Data gapFallback financials|
SA 59/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-116.4M · quality 43.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 9/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

59/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · DEEPAKCHEM.BOLocal privado en este navegador · Deepak Chemtex Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$943M

P/E

8.4x

↓

EV/EBITDA

4.7x

↓

ROE

22.4%

↑

Gross Margin

37.1%

↑

Debt/Equity

0.02

↓
52-Week Range$87
$69$170

TradingView lightweight chart

DEEPAKCHEM.BO price, volumen y niveles de valoración

Último $95.80Periodo -33.4%
Fair value: $86.76

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+13.7%

FCF CAGR

—

FCF margin

-14.7%

FCF / Net income

-0.94x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $794.5M · net income $123.6M · FCF $-116.4M

2022-FY → 2025-FY

Gross margin

37.1%+10.8% pts

Operating margin

18.1%+8.1% pts

Net margin

15.6%+7.7% pts

FCF margin

-14.7%-14.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$794.5M$794.5M$493.5M$467.0M$541.1M
Net Income$123.6M$123.6M$59.7M$61.2M$42.3M
EBITDA$190.6M$190.6M$91.9M$88.8M$62.6M
EPS11.5111.516.715.633.89
Gross Margin37.1%37.1%35.6%32.8%26.2%
Operating Margin18.1%18.1%14.6%15.4%10.0%
Net Margin15.6%15.6%12.1%13.1%7.8%
Balance Sheet
Debt/Equity0.020.020.040.090.21
Current Ratio6.996.99———
Cash Flow
Free Cash Flow$-116.4M$-116.4M$-201.3M$13.3M$-452000.00
Returns
ROE22.4%22.4%14.2%39.0%45.1%
Valuation
P/E8.428.42———
EV/EBITDA4.704.70———
P/B1.711.71———
Growth & Yield
Revenue Growth61.0%61.0%5.7%-13.7%—
EPS Growth71.5%71.5%19.1%44.6%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-12.5%

fácil

EPS terminal req.

$7.70

Spread vs growth

84.1%

5Y implied EPS CAGR

-4.1%

fácil

EPS terminal req.

$9.32

Spread vs growth

75.7%

10Y implied EPS CAGR

2.7%

fácil

EPS terminal req.

$15.00

Spread vs growth

68.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -13.7%

Total return

-13.7%

Start / end P/E

16.5x → 8.3x

EPS bridge

6.71 → 11.51

Residual

-35.5%

EPS growth+71.5%
Multiple rerating-49.7%
Dividend+0.0%
Residual / FX / buybacks / cross-term-35.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.